Lilly Eli Co (LLY)

01:51 AM

Eli Lilly and Novo Nordisk are tackling heart health next - Yahoo

01:51 AM

12:39 PM

Eli Lilly's Cholesterol Drug Reduces Genetic Heart Disease Risk Factor By 93.9% - Benzinga

12:39 PM

12:37 PM

Palatin Technologies' Obesity Drug Co-Administered With Eli Lilly's Blockbuster Drug Shows 4.4% Reduction In Weight - Benzinga

12:37 PM

11:53 AM

Lilly study data reinforce potential of new kind of heart drug - BioPharma Dive

11:53 AM

04:24 AM

Lilly links lepodisiran to durably lower lipoprotein in phase 2, providing edge over Amgen and Novartis - Fierce Biotech

04:24 AM

12:20 PM

Eli Lilly Launches Mounjaro in India, Faces Growing Competition in Obesity Drug Market - IndiaMedToday

12:20 PM

Mar 30, 2025

Experimental Lilly drug cuts genetic heart disease risk factor by 94% in trial - Reuters

Mar 30, 2025

Mar 30, 2025

Lilly's lepodisiran reduced levels of genetically inherited heart disease risk factor, lipoprotein(a), by nearly 94% from baseline at the highest tested dose in adults with elevated levels - Eli Lilly and Company

Mar 30, 2025

Mar 30, 2025

Revolutionary Results: Lilly's New Heart Drug Cuts Major Risk Factor by 94% in Clinical Trial - Stock Titan

Mar 30, 2025

Mar 30, 2025

1 Growth Stock With Major Catalysts on the Way to Buy and Hold - The Motley Fool

Mar 30, 2025

Mar 28, 2025

Eli Lilly Alzheimer’s Drug Kisunla Fails to Get EU Backing - Mint

Mar 28, 2025

Mar 28, 2025

Eli Lilly Stock Up 1% After Key Signal, Despite S&P 500's ~2% Drop - Benzinga

Mar 28, 2025

Mar 28, 2025

Eli Lilly’s Alzheimer’s drug gets thumbs down from EU regulator - Sherwood News

Mar 28, 2025

Mar 28, 2025

European Drug Regulator Gives Thumbs Down To Eli Lilly's Alzheimer's Drug, Analyst Says It Is Incremental Win For Biogen - Benzinga

Mar 28, 2025

Mar 28, 2025

Eli Lilly's Alzheimer's drug is rejected by EU regulators over brain swelling risk, despite U.S. approval - Yahoo

Mar 28, 2025

Mar 28, 2025

Eli Lilly Alzheimer’s drug Kisunla fails to get EU backing - Toronto Sun

Mar 28, 2025

Mar 28, 2025

European committee says Lilly Alzheimer's drug shouldn't get marketing approval - The Times of Northwest Indiana

Mar 28, 2025

Mar 28, 2025

European committee says Lilly Alzheimer’s drug shouldn’t get marketing approval - Winnipeg Free Press

Mar 28, 2025

Mar 28, 2025

Eli Lilly's Alzheimer's drug rejected in Europe - Reuters.com

Mar 28, 2025

Mar 28, 2025

Eli Lilly Alzheimer’s Drug Kisunla Fails To Get EU Backing - NDTV Profit

Mar 28, 2025

Mar 28, 2025

Billionaire Ken Fisher’s #2 Low Vol Stock Pick: Eli Lilly & Company (LLY) - Insider Monkey

Mar 28, 2025

Mar 28, 2025

Eli Lilly Alzheimer’s drug fails to win EU nod (LLY:NYSE) - Seeking Alpha

Mar 28, 2025

Mar 28, 2025

EU regulator declines approval for Eli Lilly’s new Alzheimer’s drug - Financial Times

Mar 28, 2025

Mar 28, 2025

Eli Lilly’s Alzheimer’s drug gets thumbs-down from European regulators - statnews.com

Mar 28, 2025

Mar 28, 2025

Eli Lilly Remains Confident In The Safety And Effectiveness Of Donanemab - Marketscreener.com

Mar 28, 2025

Mar 28, 2025

Lilly stock dips as Kisunla misses EU approval By Investing.com - Investing.com South Africa

Mar 28, 2025

Mar 28, 2025

Lilly stock dips as Kisunla misses EU approval - Investing.com

Mar 28, 2025

Mar 28, 2025

Lilly’s statement about the CHMP opinion issued for donanemab | Eli Lilly and Company - Eli Lilly and Company

Mar 28, 2025

Mar 28, 2025

Eli Lilly & Co. (LLY) call put ratio 1 call to 1.3 puts - StreetInsider

Mar 28, 2025

Mar 28, 2025

Eli Lilly and Company (NYSE:LLY) Shares Down 0.2%Here's What Happened - MarketBeat

Mar 28, 2025

Mar 27, 2025

Lilly adds Alzheimer's to online offerings - Reuters

Mar 27, 2025

Mar 27, 2025

Here's How Much $1000 Invested In Eli Lilly 20 Years Ago Would Be Worth Today - Benzinga

Mar 27, 2025

Mar 27, 2025

Eli Lilly Says Michigan AG's Insulin Pricing Probe Is Baseless - Law360

Mar 27, 2025

Mar 27, 2025

Eli Lilly and Company (LLY): Among Dividend Zombies to Invest in - Yahoo Finance

Mar 27, 2025

Mar 27, 2025

Eli Lilly expands LillyDirect to include Alzheimer's resources - Seeking Alpha

Mar 27, 2025

Mar 27, 2025

Eli Lilly taps Chicago startup as it expands digital health platform - Crain's Chicago Business

Mar 27, 2025

Mar 27, 2025

Eli Lilly's online health platform just expanded beyond weight loss to tackle Alzheimer’s - Yahoo

Mar 27, 2025

Mar 27, 2025

Beyond GLP-1 Drugs: This Opportunity at Eli Lilly Could Surprise Everyone in 2025 - AOL

Mar 27, 2025

Mar 27, 2025

LillyDirect Platform Expands To Facilitate Access To Alzheimer's Disease Care - Marketscreener.com

Mar 27, 2025

Mar 27, 2025

LillyDirect platform expands to facilitate access to Alzheimer's disease care - Eli Lilly and Company

Mar 27, 2025

Mar 27, 2025

In a first, Eli Lilly to connect patients to telehealth providers of Alzheimer’s care - statnews.com

Mar 27, 2025

Mar 27, 2025

Lilly Expands Digital Health Site to Include Alzheimer’s Disease - Bloomberg.com

Mar 27, 2025

Mar 26, 2025

Eli Lilly comms head Kathryn Beiser resigns - PRWeek

Mar 26, 2025

Mar 26, 2025

Eli Lilly's GLP-1 pill could be the next key in obesity treatment - Yahoo Finance

Mar 26, 2025

Mar 26, 2025

Eli Lilly and Company (LLY): One of Two Sigma Investments’ Top Stock Picks - Yahoo Finance

Mar 26, 2025

Mar 26, 2025

Eli Lilly (LLY) Stock: Why Analysts See 30% Upside Potential - MoneyCheck

Mar 26, 2025

Mar 26, 2025

Eli Lilly, Palo Alto Networks Traders Take Note: Direxion's New Leveraged ETFs Are Here - Benzinga

Mar 26, 2025

Mar 26, 2025

Eli Lilly CEO invites job seekers for new Hyderabad tech hub | Exclusive - CNBCTV18

Mar 26, 2025

Mar 26, 2025

Mounjaro: Here Is How Eli Lilly Shares Have Performed Since The Launch Its Own Ozempic - Free Press Journal

Mar 26, 2025

Mar 26, 2025

Eli Lilly plans to expand insulin access for diabetics, NCD therapies in India - Business Today

Mar 26, 2025

Mar 25, 2025

Open to tie-ups in India for selling Mounjaro: Eli Lilly CEO David Ricks - The Economic Times

Mar 25, 2025